USPTO serial 79027343
CANDICYD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, EUGENIA K
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CANDICYD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Haverly A. Rauen
Haverly A. Rauen Adams and Reese, LLP424 Church StreetSuite 2800Nashville, TN 37219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products comprising bacterial cultures for medical and veterinary use, in particular bacterial cultures in solid, dispersive, liquid and cream form, namely tablets, pills, capsules, granules, pessaries, dispersable powders, syrups, creams, oils, ointments, for the treatment and elimination of bacteria, fungi and viruses present on the skin and in the mucous membranes; pharmaceutical products comprising bacterial cultures for topical and oral use for the preventive and curative treatment of vaginal diseases and abnormalities; bacterial cultures for the preparation of pharmaceutical products for medical and veterinary use; bacterial cultures for the treatment and elimination of bacteria, fungi and viruses present on the skin and in the mucous membranes, for medical and veterinary use; bacterial cultures for the production of pharmaceutical products for topical and oral use for the preventive and curative treatment of vaginal diseases and abnormalities; microorganism cultures, in particular lactic bacteria having probiotic action on the human organism and on the animal species, bred for medical and veterinary use | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2011 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 3, 2011 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 29, 2011 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 31, 2010 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 3, 2009 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 9, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 7, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 2, 2008 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 14, 2008 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 10, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 7, 2008 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Mar 7, 2008 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Mar 7, 2008 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Dec 14, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 20, 2007 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 19, 2007 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Nov 17, 2007 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Aug 20, 2007 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 24, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 4, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 7, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 3, 2007 | ALIE | ASSIGNED TO LIE | — |
| Apr 13, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 5, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 4, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 4, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 13, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 13, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 12, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 11, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 28, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |